Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
What each said, in their own words
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
Innovation is the lifeblood of the biopharmaceutical industry and has delivered some of the most incredible life-changing innovations for safeguarding and improving health. Policy and legal frameworks must therefore continue to incentivise and create environments that drive innovation for long-term wellbeing and economic growth, as well as providing solid platforms for response to new and emerging health threats.
Please find enclosed the opinion of the German Lawyers’ Association (DAV) by the Intellectual Property Committee on the Commission’s impact assessment on compulsory licensing in the EU. The DAV welcomed in principle an evaluation of the compulsory licensing system for patents. However, the DAV is critical of the creation of a uniform system of compulsory licensing in the EU.
Filed in German · English published by the European Commission
The Deutscher Anwaltverein (DAV) is the professional association for lawyers in Germany; membership is optional. The DAV brings together more than 61 000 lawyers and notaries of lawyers, organised in 252 local lawyers’ clubs at home and abroad. He represents the interests of the German Bar at national, European and international level. This opinion responds to the Commission’s request of 8.3.2022.
Filed in German · English published by the European Commission
INTERPAT is a global trade association of Chief intellectual property (IP) Counsels from the biopharmaceutical industry that seeks to share knowledge, experience and expertise in creating and nurturing sustainable innovation ecosystems in life sciences.
Take this comparison with you
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.